awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33411190-029E4D40-83A9-4442-9EF6-D2A3274E7F18
Q33411190-029E4D40-83A9-4442-9EF6-D2A3274E7F18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411190-029E4D40-83A9-4442-9EF6-D2A3274E7F18
Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.
P2860
Q33411190-029E4D40-83A9-4442-9EF6-D2A3274E7F18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411190-029E4D40-83A9-4442-9EF6-D2A3274E7F18
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfdd08da66d09885d613dfed6733aa4341f2e53d
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.